SCYB
vs
S&P TSX Composite Index (Canada)
Over the past 12 months, SCYB has underperformed S&P TSX Composite Index (Canada), delivering a return of -50% compared to the S&P TSX Composite Index (Canada)'s 22% growth.
Stocks Performance
SCYB vs S&P TSX Composite Index (Canada)
Performance Gap
SCYB vs S&P TSX Composite Index (Canada)
Performance By Year
SCYB vs S&P TSX Composite Index (Canada)
Scryb Inc
Glance View
Scryb, Inc. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. The company is headquartered in Etobicoke, Ontario. The Company’s platform offers businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The platform adopts across diverse markets, from digital health and diagnostics to cybersecurity and manufacturing. The Company’s cloud-based platform is composed of elements including sensor technology, Internet of things (IoT), predictive analytics, and computer vision. Its portfolio includes Pharmatrac, Fionet, Handheld Diagnostics and Cybeats. Pharmatrac is an artificial intelligence (AI) digital health company that provides insight into medication behavior. Fionet is a data-and-device platform that enables controlled testing and tracking for pandemic response. Handheld Diagnostics brings lab-quality analysis to bedside in critical care situations. Cybeats builds certainty in software security.